Form 8-K - Current report:
SEC Accession No. 0001493152-23-002313
Filing Date
2023-01-24
Accepted
2023-01-24 16:00:30
Documents
15
Period of Report
2023-01-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40864
2 ex99-1.htm EX-99.1 15084
3 ex99-1_001.jpg GRAPHIC 9460
  Complete submission text file 0001493152-23-002313.txt   292694

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biaf-20230124.xsd EX-101.SCH 3990
5 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT biaf-20230124_def.xml EX-101.DEF 26626
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biaf-20230124_lab.xml EX-101.LAB 36673
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biaf-20230124_pre.xml EX-101.PRE 25250
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5569
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 23548116
SIC: 8731 Services-Commercial Physical & Biological Research